Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Pimavanserin (Nuplazid)

NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

Each tablet contains 17mg of pimavanserin.

  • Trade name: ​Nuplazid
  • Manufacturer: Acadia Pharmaceuticals.
  • Presentation: Tablet
  • Strength:  17mg  
  • Pack Size: 60 Tablets
  • Pack Insert: yes
  • National Drug Code: NA
  • Marketing Authorization Holder: No
  • Manufacturing License: NDC 63090-170-60